Clinical trial
Clinical Trial for Prostate Cancer
NCT00076531 · Oakwood Laboratories, LLC, Industry · Completed
Key facts
| NCT number | NCT00076531 |
|---|---|
| Title | Clinical Trial for Prostate Cancer |
| Lead sponsor | Oakwood Laboratories, LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Leuprolide Acetate for Injectable Suspension 22.5 mg |
| Start date | Dec 1, 2003 |
| Primary completion | Nov 1, 2004 |
| First posted | Jan 27, 2004 |
| Last update posted | Jan 28, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: